DNER and rhabdomyosarcoma: Regarding soft-tissue sarcomas, several studies have demonstrated antitumor activity of BET inhibitors using Ewing sarcoma, rhabdomyosarcoma, and clear cell sarcoma cells through mechanisms similar to those of hematological tumor cells [17,22,23].